Novartis AG Net Income

Novartis AG (NVSEF) currently reports a net income of $13B as of June 2026. That compares with $14B in the prior-year period — down 8.3% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Novartis AG's net income history and peer comparisons.

Novartis AG's net income decreased from $14B to $13B — a 8.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novartis AG's net income of $13B is lower than the Healthcare sector average of $16B. That is roughly 20.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Novartis AG reported $13B in net income as of June 2026. That compares with $14B in the prior-year period — down 8.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $13B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Novartis AG, and consider following NVSEF for alerts when major investors trade the stock.